Fermion is an AI-enabled drug discovery company developing small-molecule therapeutics. Its Drug Studio AI platform uses deep learning, reinforcement learning, GANs, big data, and knowledge graphs to rapidly generate, screen, and optimize molecules with favorable properties. The company focuses on neurology and autoimmune diseases, progressing assets from early research through IND-enabling studies toward clinical trials, and collaborates with partners to advance high-potential programs.